EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Clinical and pathological pitfalls in invasive lobular carcinoma presenting as an ileocecal stricture: When E-cadherin deceives, and β-catenin decides

Juwain Shehzad Nehil, Vikas Karamchand Dagar, Indranil Chakrabarti, Pranay Kabiraj, Debanjan Nandi

Journal of Laboratory Physicians · 2026-06-05 · 18 · 474-478

DOI: 10.25259/jlp_357_2025 ↗
AbstractBibliografische Angaben

Abstract

A 47-year-old woman presented with acute intestinal obstruction. Contrast-enhanced computed tomography suggested an ileocecal stricture, and an emergency right hemicolectomy was performed. Grossly, an annular stricture with intact mucosa was identified. Histology showed diffuse mural infiltration by discohesive tumor cells arranged in cords and single-file strands with mucosal sparing, favoring metastatic invasive lobular carcinoma (ILC). Targeted review revealed a neglected right-breast mass, core biopsy showed hormone-receptor-positive, human epidermal growth factor 2-negative carcinoma with lobular morphology, and low Ki-67. Immunohistochemistry demonstrated breast lineage (GATA3-positive) and aberrant/retained E-cadherin with p120 catenin cytoplasmic redistribution (with residual membranous staining) and loss of membranous β-catenin, supporting ILC with aberrant E-cadherin expression rather than ductal carcinoma. The patient was referred for systemic therapy. This case illustrates a “double deception,” a clinical mimic of ileocaecal tuberculosis or primary colonic carcinoma and a pathological pitfall due to deceptively retained E-cadherin staining, underscoring the risk of misdiagnosis and the critical importance of careful microscopic morphology and a high index of suspicion, supported by a morphology-first, panel-based immunohistochemical approach (E-cadherin/p120/β-catenin) when E-cadherin expression is aberrant.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →